ImmunityBio Inc (IBRX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -35.306 | -33.956 | -44.509 | -40.476 | -62.637 | -111.729 | -100.225 | -134.562 |
Return on Equity (%) | -37.206 | -37.646 | -52.748 | -49.338 | -77.609 | 548.198 | 120.094 | 112.613 |
Return on Invested Capital (%) | -47.361 | -48.897 | -60.891 | -56.906 | -85.65 | -420.858 | 418.929 | 540.068 |
Operating Margin (%) | -275715.909 | -213995.556 | -204885.106 | -153179.07 | -83186.486 | -35866.167 | -147404.583 | -73101.929 |
Net Profit Margin (%) | -274565.909 | -214273.333 | -204736.17 | -152997.674 | -83227.928 | -37129.55 | -173569.583 | -93761.415 |
Book Value Per Share | 1.561 | 1.189 | 0.8 | 0.6 | 0.555 | -0.506 | -0.896 | -0.783 |
Earnings Per Share | -0.654 | -0.531 | -0.529 | -0.327 | -0.437 | -0.715 | -0.795 | -0.757 |
Cash Per Share | 0.044 | 0.131 | 0.093 | 0.077 | 0.054 | 0.373 | 0.2 | 0.345 |
Working Capital Per Share | 1.043 | 0.614 | 0.338 | 0.22 | 0.241 | -0.071 | -0.687 | 0.306 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | 0.001 | 0.002 | N/A | 0.001 |
EBIT Per Share | -0.657 | -0.533 | -0.532 | -0.328 | -0.437 | -0.721 | -0.796 | -0.758 |
EBITDA Per Share | -0.657 | -0.533 | -0.532 | -0.328 | -0.437 | -0.721 | -0.796 | -0.758 |
Free Cash Flow Per Share | -0.638 | -0.37 | -0.51 | -0.351 | -0.468 | -0.675 | -0.64 | -0.741 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 81,98M | 79,02M | 79,09M | 98,46M | 108,73M | 382,24M | 421,57M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 397,83M | 421,57M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -24101.944 | N/A | N/A | N/A | -241607.5 | N/A |
Net Profit Margin (%) | N/A | N/A | -32317.5 | N/A | N/A | N/A | -335272.5 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,42B |
Ratio cours/bénéfice | -38,82 |
Ratio prix/ventes | 36,1k |
Ratio prix/liquidités | 85,3 |
Ratio prix/valeur comptable | -38,64 |
Rendement de dividende | - |
Actions en circulation | 696,83M |
Volume moyen (1 semaine) | 7,3M |
Volume moyen (1 mois) | 7,11M |
Variation sur 52 semaines | -1,16% |
Plus haut sur 52 semaines | 10,53 |
Plus bas sur 52 semaines | 2,28 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales